HNN3.0
Register
Register
Register

Project cooperationUpdated on 26 January 2026

Exploring partnerships || discovery, POC, commercialization, valorization

Executive Director HDI Group, EIC innovation expert at Human Data Insight Group

Bucharest, Romania

About

About

Human Data Insight Group (HDI) is a health and life sciences innovation and impact organisation supporting Horizon Europe Cluster Health projects with early discovery, applied innovation, and real-world uptake capabilities. HDI works at the intersection of health systems, behavioural insight, and early-stage technical validation, helping consortia ensure that research outcomes are grounded in real needs and translated into trusted, usable solutions.

HDI combines experience from EU-funded programmes, health systems, academia, and industry to bridge gaps between research, clinical practice, and innovation adoption, with a particular focus on mental health, workforce challenges, and system integration.

Project / Approach Overview

HDI’s approach is centred on problem-first innovation, ensuring that Horizon Health projects address clearly defined needs and generate outcomes that are relevant, credible, and scalable.

HDI supports projects across three tightly connected layers:

1. Discovery & problem definition

  • Identification and sizing of unmet needs (e.g. staff shortages, care fragmentation, mental health access gaps)

  • Quantitative and qualitative analyses (surveys, questionnaires, mixed methods)

  • Behavioural insight to understand how challenges manifest in daily clinical and system workflows

2. Co-creation & early technical validation (POC level)

  • Design and facilitation of hackathons, living labs, and behavioural labs with students, clinicians, and experts

  • Early proof-of-concept (TRL 2–4) development for:

    • interoperability concepts across fragmented tools and services

    • workflow and coordination solutions addressing clinician workload and staff shortages

    • clinician-facing mental health interventions supporting continuity of care and ethical practice

  • Feasibility testing and user validation in real-world contexts

  1. Commercialization

    HDI Group provides world-class EU project management and commercialization expertise, having successfully secured and managed health projects. Our extensive network spans 200+ stakeholders including health tech accelerators, venture capital firms, and strategic corporate partners across Europe.

•         Project management: 100% on-time delivery rate, experienced in multi-regional consortium coordination, established relationships with UNITE regional representatives

•         Market access: Partnerships with 5 EU health accelerators, connections to 15+ hospital networks, established pathways in 7 EU markets

4. Valorisation, uptake & sustainability

  • Communication, dissemination, and outreach aligned with Horizon requirements

  • Stakeholder engagement with universities, healthcare providers, industry, insurers, and policymakers

  • Support for transforming validated concepts into initiatives, services, or entrepreneurial pathways

  • Impact measurement and sustainability planning beyond the project lifecycle

HDI does not position itself as a full-scale technology developer or clinical trial operator, but as an early innovation and system-integration partner, preparing concepts for downstream development by specialised partners.Role in the Consortium

HDI seeks to participate as a beneficiary and applied innovation partner, contributing to both strategic and hands-on activities.

HDI may also act as work-package leader or coordinator for selected Coordination and Support Actions (CSAs) or system-focused RIAs.

Type of Partners Sought

HDI is looking to collaborate within Horizon Europe Cluster Health consortia with:

  • Universities and research organisations

  • Hospitals and mental health service providers

  • Technology partners for scaling and advanced development

  • Public authorities, insurers, and policy stakeholders

  • Coordinators seeking partners strong in discovery, engagement, and impact

HDI values consortia that recognise early validation, co-creation, and uptake as critical success factors alongside scientific excellence.

Collaboration Interest

HDI is open to joining consortia as:

  • An early innovation and discovery partner

  • A POC-level technical contributor focused on interoperability and clinician support

  • A work-package leader for co-creation, engagement, valorisation, and impact

  • A core partner bridging research outputs with system and societal needs

Topic

  • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

Type

  • Partner seeks Consortium/Coordinator

Organisation

Human Data Insight Group

Consultancy

Bucharest, Romania

Similar opportunities

  • Project cooperation

    Low value care || Agentic AI || mental health

    • Partner seeks Consortium/Coordinator
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems

    Diana Pirjol

    Executive Director HDI Group, EIC innovation expert at Human Data Insight Group

    Bucharest, Romania

  • Project cooperation

    Digital Health Co-design, Research and Innovation, Evaluation

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults

    Giulia Mezzanotte

    European Project Manager at Fondazione Bruno Kessler

    TRENTO, Italy

  • Project cooperation

    TRANSLATE-HEALTH: Translational Training & Validation Hubs for Next-Generation Healthcare Technologies

    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches

    Luca Takács

    Founder and CEO at LNP Academy

    Budapest, Hungary